FDA recall,
Eugia Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)
Vancomycin Hydrochloride for Injection contains a glass particle that can cause serious health consequences.
What happened
Eugia US LLC, formerly known as Auro Medics Pharma LLC, is voluntarily recalling Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) nationwide, reaching the businesses and people who have the product. The recall is due to tiny pieces of material that do not belong in the product, identified as a glass particle inside the vial.
The company says use of product containing glass particles can cause serious adverse health consequences, including blockage and clotting in blood vessels that can cut off blood flow to vital organs. It also lists a life-threatening blood clot in the lungs (pulmonary embolism), and permanent organ damage or death.
The particles may also cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, and allergic reactions. Greater susceptibility may exist in neonates, infants and patients with compromised organ function. To date, the company has not received any reports of adverse events related to this recall.
The recall covers a lot of the product. The product is packaged in 30 mL vials, and can be identified by the product name on the carton and vial labels. Eugia US LLC shipped the entire lot to wholesalers nationwide from September 2, 2026, through September 15, 2026.
What to do
If a code on your package is listed below:
- Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.
- Questions, or want to report an adverse event? Contact Eugia US LLC from 8:00 am to 5:00 p.m. (EST) Monday to Friday at 1-866-850-2876 Option 2 or pvg@
aurobindousa.com.
For stores and distributors: Wholesalers/hospitals/pharmacies, institutions, and doctors with existing inventory of the recalled product lot should discontinue use and quarantine the product immediately. If you have further distributed the recalled product lot, notify your accounts and or any additional locations which may have received the recalled product. Hospitals and institutions should inform Healthcare professionals in your organization of this recall.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial)
- NDC
- 55150-471-01
- 55150-471-10
- Lot code
- 3VM26026A
From the FDA notice
The recalled product is packaged in 30 mL vial and packed as 10 (vials) X 10 (Printed cartons) X 01 (Shipper) with NDC code as 55150-471-01.
The product can be identified by product name on carton (NDC 55150-471-10) and vial (NDC 55150-471-01) label and with lot number 3VM26026A and Exp.
Recall details
- Company announced
- Weekly archive
- Listed the week of Nov 9, 2026
- Sold in
- Nationwide
Per the FDA notice.
- Recalled by
- Eugia US LLC (formerly Auro Medics Pharma LLC)
- Hazard
- Foreign object
All recalls from Eugia US LLC (formerly Auro Medics Pharma LLC)



